These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 22245771)
1. Cardiac-specific genetic inhibition of nuclear factor-κB prevents right ventricular hypertrophy induced by monocrotaline. Kumar S; Wei C; Thomas CM; Kim IK; Seqqat R; Kumar R; Baker KM; Jones WK; Gupta S Am J Physiol Heart Circ Physiol; 2012 Apr; 302(8):H1655-66. PubMed ID: 22245771 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice. Li L; Wei C; Kim IK; Janssen-Heininger Y; Gupta S Hypertension; 2014 Jun; 63(6):1260-9. PubMed ID: 24614212 [TBL] [Abstract][Full Text] [Related]
3. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775 [TBL] [Abstract][Full Text] [Related]
4. Intralipid prevents and rescues fatal pulmonary arterial hypertension and right ventricular failure in rats. Umar S; Nadadur RD; Li J; Maltese F; Partownavid P; van der Laarse A; Eghbali M Hypertension; 2011 Sep; 58(3):512-8. PubMed ID: 21747043 [TBL] [Abstract][Full Text] [Related]
5. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response. Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ Molecules; 2018 May; 23(6):. PubMed ID: 29861433 [TBL] [Abstract][Full Text] [Related]
6. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation. Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823 [TBL] [Abstract][Full Text] [Related]
7. Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats. Campos-Carraro C; Turck P; de Lima-Seolin BG; Tavares AMV; Dos Santos Lacerda D; Corssac GB; Teixeira RB; Hickmann A; Llesuy S; da Rosa Araujo AS; Belló-Klein A J Cardiovasc Pharmacol; 2018 Nov; 72(5):214-221. PubMed ID: 30212415 [TBL] [Abstract][Full Text] [Related]
8. Ca Sabourin J; Boet A; Rucker-Martin C; Lambert M; Gomez AM; Benitah JP; Perros F; Humbert M; Antigny F J Mol Cell Cardiol; 2018 May; 118():208-224. PubMed ID: 29634917 [TBL] [Abstract][Full Text] [Related]
9. Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension. Piao L; Fang YH; Parikh K; Ryan JJ; Toth PT; Archer SL J Mol Med (Berl); 2013 Oct; 91(10):1185-97. PubMed ID: 23794090 [TBL] [Abstract][Full Text] [Related]
10. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats. Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079 [TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats. Sun X; Ku DD Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H801-9. PubMed ID: 18055512 [TBL] [Abstract][Full Text] [Related]
12. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension. Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952 [TBL] [Abstract][Full Text] [Related]
13. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. Piao L; Fang YH; Cadete VJ; Wietholt C; Urboniene D; Toth PT; Marsboom G; Zhang HJ; Haber I; Rehman J; Lopaschuk GD; Archer SL J Mol Med (Berl); 2010 Jan; 88(1):47-60. PubMed ID: 19949938 [TBL] [Abstract][Full Text] [Related]
14. [Effect of chrysin on expression of NOX4 and NF-κB in right ventricle of monocrotaline-induced pulmonary arterial hypertension of rats]. Li XW; Guo B; Shen YY; Yang JR Yao Xue Xue Bao; 2015 Sep; 50(9):1128-34. PubMed ID: 26757549 [TBL] [Abstract][Full Text] [Related]
15. Thymosin Beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. Wei C; Kim IK; Li L; Wu L; Gupta S PLoS One; 2014; 9(11):e110598. PubMed ID: 25412097 [TBL] [Abstract][Full Text] [Related]
16. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension. Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933 [TBL] [Abstract][Full Text] [Related]
17. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1. Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422 [TBL] [Abstract][Full Text] [Related]
18. Ursolic Acid Improves Monocrotaline-Induced Right Ventricular Remodeling by Regulating Metabolism. Gao X; Zhang Z; Li X; Wei Q; Li H; Li C; Chen H; Liu C; He K J Cardiovasc Pharmacol; 2020 Jun; 75(6):545-555. PubMed ID: 32141989 [TBL] [Abstract][Full Text] [Related]
19. Decreased Expression of Canstatin in Rat Model of Monocrotaline-Induced Pulmonary Arterial Hypertension: Protective Effect of Canstatin on Right Ventricular Remodeling. Sugiyama A; Kaisho M; Okada M; Otani K; Yamawaki H Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947968 [TBL] [Abstract][Full Text] [Related]
20. GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension. Piao L; Fang YH; Parikh KS; Ryan JJ; D'Souza KM; Theccanat T; Toth PT; Pogoriler J; Paul J; Blaxall BC; Akhter SA; Archer SL Circulation; 2012 Dec; 126(24):2859-69. PubMed ID: 23124027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]